Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
CELL similar filings
- 5 May 23 Cost Associated with Exit or Disposal Activities
- 28 Apr 23 Departure of Directors or Certain Officers
- 10 Apr 23 PhenomeX Appoints Peter Silvester to PhenomeX Board of Directors
- 21 Mar 23 Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company
- 16 Mar 23 Submission of Matters to a Vote of Security Holders
- 10 Mar 23 Regulation FD Disclosure
- 6 Mar 23 Unaudited Pro Forma Condensed Combined Financial Statements
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration No. 333- 258704 on Form S-3, and Registration Statement No. 333-239987, 333-254399, 333-263243 and 333-270041 on Form S-8 of PhenomeX Inc. of our report dated March 2, 2023, relating to the financial statements of IsoPlexis Corporation incorporated by reference in this Current Report on Form 8-K dated March 21, 2023 appearing in the Annual Report on Form 10-K of IsoPlexis Corporation for the year ended December 31, 2022.
/s/ Deloitte & Touche LLP
Hartford, Connecticut
March 21, 2023